1 Cancer Radiotherapy Market Overview 1.1 Product Overview and Scope of Cancer Radiotherapy 1.2 Cancer Radiotherapy Segment by Type 1.2.1 Global Cancer Radiotherapy Market Value Comparison by Type (2023-2029) 1.2.2 External Beam Radiotherapy 1.2.3 Internal Beam Radiotherapy 1.2.4 Systemic Radiotherapy 1.2.5 Intravenous Radiotherapy 1.2.6 Oral Radiotherapy 1.2.7 Instillation Radiotherapy 1.3 Cancer Radiotherapy Segment by Application 1.3.1 Global Cancer Radiotherapy Market Value by Application: (2023-2029) 1.3.2 Hospitals 1.3.3 Independent Radiotherapy Centers 1.4 Global Cancer Radiotherapy Market Size Estimates and Forecasts 1.4.1 Global Cancer Radiotherapy Revenue 2018-2029 1.4.2 Global Cancer Radiotherapy Sales 2018-2029 1.4.3 Global Cancer Radiotherapy Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Cancer Radiotherapy Market Competition by Manufacturers 2.1 Global Cancer Radiotherapy Sales Market Share by Manufacturers (2018-2023) 2.2 Global Cancer Radiotherapy Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Cancer Radiotherapy Average Price by Manufacturers (2018-2023) 2.4 Global Cancer Radiotherapy Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Cancer Radiotherapy, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Cancer Radiotherapy, Product Type & Application 2.7 Cancer Radiotherapy Market Competitive Situation and Trends 2.7.1 Cancer Radiotherapy Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Cancer Radiotherapy Players Market Share by Revenue 2.7.3 Global Cancer Radiotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Cancer Radiotherapy Retrospective Market Scenario by Region 3.1 Global Cancer Radiotherapy Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Cancer Radiotherapy Global Cancer Radiotherapy Sales by Region: 2018-2029 3.2.1 Global Cancer Radiotherapy Sales by Region: 2018-2023 3.2.2 Global Cancer Radiotherapy Sales by Region: 2024-2029 3.3 Global Cancer Radiotherapy Global Cancer Radiotherapy Revenue by Region: 2018-2029 3.3.1 Global Cancer Radiotherapy Revenue by Region: 2018-2023 3.3.2 Global Cancer Radiotherapy Revenue by Region: 2024-2029 3.4 North America Cancer Radiotherapy Market Facts & Figures by Country 3.4.1 North America Cancer Radiotherapy Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Cancer Radiotherapy Sales by Country (2018-2029) 3.4.3 North America Cancer Radiotherapy Revenue by Country (2018-2029) 3.4.4 United States 3.4.5 Canada 3.5 Europe Cancer Radiotherapy Market Facts & Figures by Country 3.5.1 Europe Cancer Radiotherapy Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Cancer Radiotherapy Sales by Country (2018-2029) 3.5.3 Europe Cancer Radiotherapy Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Cancer Radiotherapy Market Facts & Figures by Country 3.6.1 Asia Pacific Cancer Radiotherapy Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Cancer Radiotherapy Sales by Country (2018-2029) 3.6.3 Asia Pacific Cancer Radiotherapy Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 China Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.7 Latin America Cancer Radiotherapy Market Facts & Figures by Country 3.7.1 Latin America Cancer Radiotherapy Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Cancer Radiotherapy Sales by Country (2018-2029) 3.7.3 Latin America Cancer Radiotherapy Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Cancer Radiotherapy Market Facts & Figures by Country 3.8.1 Middle East and Africa Cancer Radiotherapy Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Cancer Radiotherapy Sales by Country (2018-2029) 3.8.3 Middle East and Africa Cancer Radiotherapy Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 UAE 4 Segment by Type 4.1 Global Cancer Radiotherapy Sales by Type (2018-2029) 4.1.1 Global Cancer Radiotherapy Sales by Type (2018-2023) 4.1.2 Global Cancer Radiotherapy Sales by Type (2024-2029) 4.1.3 Global Cancer Radiotherapy Sales Market Share by Type (2018-2029) 4.2 Global Cancer Radiotherapy Revenue by Type (2018-2029) 4.2.1 Global Cancer Radiotherapy Revenue by Type (2018-2023) 4.2.2 Global Cancer Radiotherapy Revenue by Type (2024-2029) 4.2.3 Global Cancer Radiotherapy Revenue Market Share by Type (2018-2029) 4.3 Global Cancer Radiotherapy Price by Type (2018-2029) 5 Segment by Application 5.1 Global Cancer Radiotherapy Sales by Application (2018-2029) 5.1.1 Global Cancer Radiotherapy Sales by Application (2018-2023) 5.1.2 Global Cancer Radiotherapy Sales by Application (2024-2029) 5.1.3 Global Cancer Radiotherapy Sales Market Share by Application (2018-2029) 5.2 Global Cancer Radiotherapy Revenue by Application (2018-2029) 5.2.1 Global Cancer Radiotherapy Revenue by Application (2018-2023) 5.2.2 Global Cancer Radiotherapy Revenue by Application (2024-2029) 5.2.3 Global Cancer Radiotherapy Revenue Market Share by Application (2018-2029) 5.3 Global Cancer Radiotherapy Price by Application (2018-2029) 6 Key Companies Profiled 6.1 Siemens Healthineers 6.1.1 Siemens Healthineers Corporation Information 6.1.2 Siemens Healthineers Description and Business Overview 6.1.3 Siemens Healthineers Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.1.4 Siemens Healthineers Cancer Radiotherapy Product Portfolio 6.1.5 Siemens Healthineers Recent Developments/Updates 6.2 Elekta 6.2.1 Elekta Corporation Information 6.2.2 Elekta Description and Business Overview 6.2.3 Elekta Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.2.4 Elekta Cancer Radiotherapy Product Portfolio 6.2.5 Elekta Recent Developments/Updates 6.3 Accuray Incorporated 6.3.1 Accuray Incorporated Corporation Information 6.3.2 Accuray Incorporated Description and Business Overview 6.3.3 Accuray Incorporated Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.3.4 Accuray Incorporated Cancer Radiotherapy Product Portfolio 6.3.5 Accuray Incorporated Recent Developments/Updates 6.4 IBA 6.4.1 IBA Corporation Information 6.4.2 IBA Description and Business Overview 6.4.3 IBA Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.4.4 IBA Cancer Radiotherapy Product Portfolio 6.4.5 IBA Recent Developments/Updates 6.5 ViewRay Technologies 6.5.1 ViewRay Technologies Corporation Information 6.5.2 ViewRay Technologies Description and Business Overview 6.5.3 ViewRay Technologies Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.5.4 ViewRay Technologies Cancer Radiotherapy Product Portfolio 6.5.5 ViewRay Technologies Recent Developments/Updates 6.6 Hitachi Ltd. 6.6.1 Hitachi Ltd. Corporation Information 6.6.2 Hitachi Ltd. Description and Business Overview 6.6.3 Hitachi Ltd. Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.6.4 Hitachi Ltd. Cancer Radiotherapy Product Portfolio 6.6.5 Hitachi Ltd. Recent Developments/Updates 6.7 iCAD, Inc. 6.6.1 iCAD, Inc. Corporation Information 6.6.2 iCAD, Inc. Description and Business Overview 6.6.3 iCAD, Inc. Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.4.4 iCAD, Inc. Cancer Radiotherapy Product Portfolio 6.7.5 iCAD, Inc. Recent Developments/Updates 6.8 IsoRay 6.8.1 IsoRay Corporation Information 6.8.2 IsoRay Description and Business Overview 6.8.3 IsoRay Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.8.4 IsoRay Cancer Radiotherapy Product Portfolio 6.8.5 IsoRay Recent Developments/Updates 6.9 Mevion Medical Systems 6.9.1 Mevion Medical Systems Corporation Information 6.9.2 Mevion Medical Systems Description and Business Overview 6.9.3 Mevion Medical Systems Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.9.4 Mevion Medical Systems Cancer Radiotherapy Product Portfolio 6.9.5 Mevion Medical Systems Recent Developments/Updates 6.10 Panacea Medical Technologies 6.10.1 Panacea Medical Technologies Corporation Information 6.10.2 Panacea Medical Technologies Description and Business Overview 6.10.3 Panacea Medical Technologies Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.10.4 Panacea Medical Technologies Cancer Radiotherapy Product Portfolio 6.10.5 Panacea Medical Technologies Recent Developments/Updates 6.11 P-cure Ltd. 6.11.1 P-cure Ltd. Corporation Information 6.11.2 P-cure Ltd. Cancer Radiotherapy Description and Business Overview 6.11.3 P-cure Ltd. Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.11.4 P-cure Ltd. Cancer Radiotherapy Product Portfolio 6.11.5 P-cure Ltd. Recent Developments/Updates 6.12 ZEISS Group 6.12.1 ZEISS Group Corporation Information 6.12.2 ZEISS Group Cancer Radiotherapy Description and Business Overview 6.12.3 ZEISS Group Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023) 6.12.4 ZEISS Group Cancer Radiotherapy Product Portfolio 6.12.5 ZEISS Group Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Cancer Radiotherapy Industry Chain Analysis 7.2 Cancer Radiotherapy Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Cancer Radiotherapy Production Mode & Process 7.4 Cancer Radiotherapy Sales and Marketing 7.4.1 Cancer Radiotherapy Sales Channels 7.4.2 Cancer Radiotherapy Distributors 7.5 Cancer Radiotherapy Customers 8 Cancer Radiotherapy Market Dynamics 8.1 Cancer Radiotherapy Industry Trends 8.2 Cancer Radiotherapy Market Drivers 8.3 Cancer Radiotherapy Market Challenges 8.4 Cancer Radiotherapy Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Cancer Radiotherapy Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Cancer Radiotherapy Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Cancer Radiotherapy Market Competitive Situation by Manufacturers in 2022 Table 4. Global Cancer Radiotherapy Sales (K Units) of Key Manufacturers (2018-2023) Table 5. Global Cancer Radiotherapy Sales Market Share by Manufacturers (2018-2023) Table 6. Global Cancer Radiotherapy Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Cancer Radiotherapy Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Cancer Radiotherapy Average Price (US$/Unit) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Cancer Radiotherapy, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Cancer Radiotherapy, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Cancer Radiotherapy, Product Type & Application Table 12. Global Key Manufacturers of Cancer Radiotherapy, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Cancer Radiotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Radiotherapy as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Cancer Radiotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Cancer Radiotherapy Sales by Region (2018-2023) & (K Units) Table 18. Global Cancer Radiotherapy Sales Market Share by Region (2018-2023) Table 19. Global Cancer Radiotherapy Sales by Region (2024-2029) & (K Units) Table 20. Global Cancer Radiotherapy Sales Market Share by Region (2024-2029) Table 21. Global Cancer Radiotherapy Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Cancer Radiotherapy Revenue Market Share by Region (2018-2023) Table 23. Global Cancer Radiotherapy Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Cancer Radiotherapy Revenue Market Share by Region (2024-2029) Table 25. North America Cancer Radiotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Cancer Radiotherapy Sales by Country (2018-2023) & (K Units) Table 27. North America Cancer Radiotherapy Sales by Country (2024-2029) & (K Units) Table 28. North America Cancer Radiotherapy Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Cancer Radiotherapy Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Cancer Radiotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Cancer Radiotherapy Sales by Country (2018-2023) & (K Units) Table 32. Europe Cancer Radiotherapy Sales by Country (2024-2029) & (K Units) Table 33. Europe Cancer Radiotherapy Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Cancer Radiotherapy Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Cancer Radiotherapy Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Cancer Radiotherapy Sales by Region (2018-2023) & (K Units) Table 37. Asia Pacific Cancer Radiotherapy Sales by Region (2024-2029) & (K Units) Table 38. Asia Pacific Cancer Radiotherapy Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Cancer Radiotherapy Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Cancer Radiotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Cancer Radiotherapy Sales by Country (2018-2023) & (K Units) Table 42. Latin America Cancer Radiotherapy Sales by Country (2024-2029) & (K Units) Table 43. Latin America Cancer Radiotherapy Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Cancer Radiotherapy Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Cancer Radiotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Cancer Radiotherapy Sales by Country (2018-2023) & (K Units) Table 47. Middle East & Africa Cancer Radiotherapy Sales by Country (2024-2029) & (K Units) Table 48. Middle East & Africa Cancer Radiotherapy Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Cancer Radiotherapy Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Cancer Radiotherapy Sales (K Units) by Type (2018-2023) Table 51. Global Cancer Radiotherapy Sales (K Units) by Type (2024-2029) Table 52. Global Cancer Radiotherapy Sales Market Share by Type (2018-2023) Table 53. Global Cancer Radiotherapy Sales Market Share by Type (2024-2029) Table 54. Global Cancer Radiotherapy Revenue (US$ Million) by Type (2018-2023) Table 55. Global Cancer Radiotherapy Revenue (US$ Million) by Type (2024-2029) Table 56. Global Cancer Radiotherapy Revenue Market Share by Type (2018-2023) Table 57. Global Cancer Radiotherapy Revenue Market Share by Type (2024-2029) Table 58. Global Cancer Radiotherapy Price (US$/Unit) by Type (2018-2023) Table 59. Global Cancer Radiotherapy Price (US$/Unit) by Type (2024-2029) Table 60. Global Cancer Radiotherapy Sales (K Units) by Application (2018-2023) Table 61. Global Cancer Radiotherapy Sales (K Units) by Application (2024-2029) Table 62. Global Cancer Radiotherapy Sales Market Share by Application (2018-2023) Table 63. Global Cancer Radiotherapy Sales Market Share by Application (2024-2029) Table 64. Global Cancer Radiotherapy Revenue (US$ Million) by Application (2018-2023) Table 65. Global Cancer Radiotherapy Revenue (US$ Million) by Application (2024-2029) Table 66. Global Cancer Radiotherapy Revenue Market Share by Application (2018-2023) Table 67. Global Cancer Radiotherapy Revenue Market Share by Application (2024-2029) Table 68. Global Cancer Radiotherapy Price (US$/Unit) by Application (2018-2023) Table 69. Global Cancer Radiotherapy Price (US$/Unit) by Application (2024-2029) Table 70. Siemens Healthineers Corporation Information Table 71. Siemens Healthineers Description and Business Overview Table 72. Siemens Healthineers Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 73. Siemens Healthineers Cancer Radiotherapy Product Table 74. Siemens Healthineers Recent Developments/Updates Table 75. Elekta Corporation Information Table 76. Elekta Description and Business Overview Table 77. Elekta Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 78. Elekta Cancer Radiotherapy Product Table 79. Elekta Recent Developments/Updates Table 80. Accuray Incorporated Corporation Information Table 81. Accuray Incorporated Description and Business Overview Table 82. Accuray Incorporated Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 83. Accuray Incorporated Cancer Radiotherapy Product Table 84. Accuray Incorporated Recent Developments/Updates Table 85. IBA Corporation Information Table 86. IBA Description and Business Overview Table 87. IBA Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 88. IBA Cancer Radiotherapy Product Table 89. IBA Recent Developments/Updates Table 90. ViewRay Technologies Corporation Information Table 91. ViewRay Technologies Description and Business Overview Table 92. ViewRay Technologies Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 93. ViewRay Technologies Cancer Radiotherapy Product Table 94. ViewRay Technologies Recent Developments/Updates Table 95. Hitachi Ltd. Corporation Information Table 96. Hitachi Ltd. Description and Business Overview Table 97. Hitachi Ltd. Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 98. Hitachi Ltd. Cancer Radiotherapy Product Table 99. Hitachi Ltd. Recent Developments/Updates Table 100. iCAD, Inc. Corporation Information Table 101. iCAD, Inc. Description and Business Overview Table 102. iCAD, Inc. Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 103. iCAD, Inc. Cancer Radiotherapy Product Table 104. iCAD, Inc. Recent Developments/Updates Table 105. IsoRay Corporation Information Table 106. IsoRay Description and Business Overview Table 107. IsoRay Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 108. IsoRay Cancer Radiotherapy Product Table 109. IsoRay Recent Developments/Updates Table 110. Mevion Medical Systems Corporation Information Table 111. Mevion Medical Systems Description and Business Overview Table 112. Mevion Medical Systems Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 113. Mevion Medical Systems Cancer Radiotherapy Product Table 114. Mevion Medical Systems Recent Developments/Updates Table 115. Panacea Medical Technologies Corporation Information Table 116. Panacea Medical Technologies Description and Business Overview Table 117. Panacea Medical Technologies Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 118. Panacea Medical Technologies Cancer Radiotherapy Product Table 119. Panacea Medical Technologies Recent Developments/Updates Table 120. P-cure Ltd. Corporation Information Table 121. P-cure Ltd. Description and Business Overview Table 122. P-cure Ltd. Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 123. P-cure Ltd. Cancer Radiotherapy Product Table 124. P-cure Ltd. Recent Developments/Updates Table 125. ZEISS Group Corporation Information Table 126. ZEISS Group Description and Business Overview Table 127. ZEISS Group Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 128. ZEISS Group Cancer Radiotherapy Product Table 129. ZEISS Group Recent Developments/Updates Table 130. Key Raw Materials Lists Table 131. Raw Materials Key Suppliers Lists Table 132. Cancer Radiotherapy Distributors List Table 133. Cancer Radiotherapy Customers List Table 134. Cancer Radiotherapy Market Trends Table 135. Cancer Radiotherapy Market Drivers Table 136. Cancer Radiotherapy Market Challenges Table 137. Cancer Radiotherapy Market Restraints Table 138. Research Programs/Design for This Report Table 139. Key Data Information from Secondary Sources Table 140. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Cancer Radiotherapy Figure 2. Global Cancer Radiotherapy Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Cancer Radiotherapy Market Share by Type in 2022 & 2029 Figure 4. External Beam Radiotherapy Product Picture Figure 5. Internal Beam Radiotherapy Product Picture Figure 6. Systemic Radiotherapy Product Picture Figure 7. Intravenous Radiotherapy Product Picture Figure 8. Oral Radiotherapy Product Picture Figure 9. Instillation Radiotherapy Product Picture Figure 10. Global Cancer Radiotherapy Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 11. Global Cancer Radiotherapy Market Share by Application in 2022 & 2029 Figure 12. Hospitals Figure 13. Independent Radiotherapy Centers Figure 14. Global Cancer Radiotherapy Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Cancer Radiotherapy Market Size (2018-2029) & (US$ Million) Figure 16. Global Cancer Radiotherapy Sales (2018-2029) & (K Units) Figure 17. Global Cancer Radiotherapy Average Price (US$/Unit) & (2018-2029) Figure 18. Cancer Radiotherapy Report Years Considered Figure 19. Cancer Radiotherapy Sales Share by Manufacturers in 2022 Figure 20. Global Cancer Radiotherapy Revenue Share by Manufacturers in 2022 Figure 21. The Global 5 and 10 Largest Cancer Radiotherapy Players: Market Share by Revenue in 2022 Figure 22. Cancer Radiotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 23. Global Cancer Radiotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 24. North America Cancer Radiotherapy Sales Market Share by Country (2018-2029) Figure 25. North America Cancer Radiotherapy Revenue Market Share by Country (2018-2029) Figure 26. United States Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 27. Canada Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 28. Europe Cancer Radiotherapy Sales Market Share by Country (2018-2029) Figure 29. Europe Cancer Radiotherapy Revenue Market Share by Country (2018-2029) Figure 30. Germany Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. France Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 32. U.K. Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 33. Italy Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 34. Russia Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 35. Asia Pacific Cancer Radiotherapy Sales Market Share by Region (2018-2029) Figure 36. Asia Pacific Cancer Radiotherapy Revenue Market Share by Region (2018-2029) Figure 37. China Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. Japan Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. South Korea Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. India Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. Australia Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. China Taiwan Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. Indonesia Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 44. Thailand Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 45. Malaysia Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 46. Latin America Cancer Radiotherapy Sales Market Share by Country (2018-2029) Figure 47. Latin America Cancer Radiotherapy Revenue Market Share by Country (2018-2029) Figure 48. Mexico Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 49. Brazil Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 50. Argentina Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 51. Middle East & Africa Cancer Radiotherapy Sales Market Share by Country (2018-2029) Figure 52. Middle East & Africa Cancer Radiotherapy Revenue Market Share by Country (2018-2029) Figure 53. Turkey Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 54. Saudi Arabia Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 55. UAE Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million) Figure 56. Global Sales Market Share of Cancer Radiotherapy by Type (2018-2029) Figure 57. Global Revenue Market Share of Cancer Radiotherapy by Type (2018-2029) Figure 58. Global Cancer Radiotherapy Price (US$/Unit) by Type (2018-2029) Figure 59. Global Sales Market Share of Cancer Radiotherapy by Application (2018-2029) Figure 60. Global Revenue Market Share of Cancer Radiotherapy by Application (2018-2029) Figure 61. Global Cancer Radiotherapy Price (US$/Unit) by Application (2018-2029) Figure 62. Cancer Radiotherapy Value Chain Figure 63. Cancer Radiotherapy Production Process Figure 64. Channels of Distribution (Direct Vs Distribution) Figure 65. Distributors Profiles Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Siemens Healthineers Elekta Accuray Incorporated IBA ViewRay Technologies Hitachi Ltd. iCAD, Inc. IsoRay Mevion Medical Systems Panacea Medical Technologies P-cure Ltd. ZEISS Group